Suchergebnisse - "Bylicki, Olivier"

PubPharm (3)

1

ROS-1 Fusions in Non-Small-Cell Lung Cancer : Evidence to Date

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Gendarme, S. | Bylicki, O. | Chouaid, C. | +1

2

Efficacy and safety of programmed cell-death-protein-1 and its ligand inhibitors in pretreated patients with epidermal growth-factor receptor-mutated or anaplastic lymphoma kinase-translocated lung adenocarcinoma

enthalten in: Medicine | 2020

von Bylicki, O. | Guisier, F. | Monnet, I. | +8

3

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

enthalten in: Targeted oncology | 2017

von Bylicki, O. | Paleiron, N. | Margery, J. | +6

1
[1]